These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9200438)

  • 21. Phospho-LAT-independent activation of the ras-mitogen-activated protein kinase pathway: a differential recruitment model of TCR partial agonist signaling.
    Chau LA; Madrenas J
    J Immunol; 1999 Aug; 163(4):1853-8. PubMed ID: 10438919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human atopen-specific types 1 and 2 T helper cell clones.
    Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
    J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-18 induces activation and association of p56(lck) and MAPK in a murine TH1 clone.
    Tsuji-Takayama K; Matsumoto S; Koide K; Takeuchi M; Ikeda M; Ohta T; Kurimoto M
    Biochem Biophys Res Commun; 1997 Aug; 237(1):126-30. PubMed ID: 9266843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of p56(lck) to p60(lck) in human peripheral blood T lymphocytes is dependent on co- stimulation through accessory receptors: involvement of phospholipase C, protein kinase C and MAP-kinases in vivo.
    Schröder AJ; Quehl P; Müller J; Samstag Y
    Eur J Immunol; 2000 Feb; 30(2):635-43. PubMed ID: 10671221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2.
    Salvadori S; Zier K
    J Immunol; 1996 Apr; 156(8):2927-32. PubMed ID: 8609413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective TCR-mediated signaling in anergic T cells.
    Migita K; Eguchi K; Kawabe Y; Tsukada T; Ichinose Y; Nagataki S; Ochi A
    J Immunol; 1995 Dec; 155(11):5083-7. PubMed ID: 7594516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn.
    Quill H; Riley MP; Cho EA; Casnellie JE; Reed JC; Torigoe T
    J Immunol; 1992 Nov; 149(9):2887-93. PubMed ID: 1357030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.
    Soares LR; Rivas A; Tsavaler L; Engleman EG
    J Immunol; 1997 Aug; 159(3):1115-24. PubMed ID: 9233604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype.
    Brinkmann V; Kinzel B; Kristofic C
    J Immunol; 1996 Jun; 156(11):4100-6. PubMed ID: 8666775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner.
    Won J; Hur YG; Hur EM; Park SH; Kang MA; Choi Y; Park C; Lee KH; Yun Y
    Eur J Immunol; 2003 Apr; 33(4):870-9. PubMed ID: 12672052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained TCR signaling is required for mitogen-activated protein kinase activation and degranulation by cytotoxic T lymphocytes.
    Berg NN; Puente LG; Dawicki W; Ostergaard HL
    J Immunol; 1998 Sep; 161(6):2919-24. PubMed ID: 9743353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in Down's syndrome.
    Scotese I; Gaetaniello L; Matarese G; Lecora M; Racioppi L; Pignata C
    Pediatr Res; 1998 Aug; 44(2):252-8. PubMed ID: 9702923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation.
    Boussiotis VA; Barber DL; Lee BJ; Gribben JG; Freeman GJ; Nadler LM
    J Exp Med; 1996 Aug; 184(2):365-76. PubMed ID: 8760790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of protein tyrosine kinases and their phosphorylation in murine Th1 cells anergized with class II MHC-peptide complexes.
    Yu SC; Nag B
    Immunol Cell Biol; 1997 Jun; 75(3):295-302. PubMed ID: 9243296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
    Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
    J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population of in vivo anergized T cells with a lower activation threshold for the induction of CD25 exhibit differential requirements in mobilization of intracellular calcium and mitogen-activated protein kinase activation.
    Utting O; Teh SJ; Teh HS
    J Immunol; 2000 Mar; 164(6):2881-9. PubMed ID: 10706673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Src-protein tyrosine kinase Lck is required for IL-1-mediated costimulatory signaling in Th2 cells.
    al-Ramadi BK; Welte T; Fernandez-Cabezudo MJ; Galadari S; Dittel B; Fu XY; Bothwell AL
    J Immunol; 2001 Dec; 167(12):6827-33. PubMed ID: 11739499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Src family kinase activity requirements for CD3 zeta phosphorylation/ZAP70 recruitment and CD3 epsilon phosphorylation.
    Lysechko TL; Ostergaard HL
    J Immunol; 2005 Jun; 174(12):7807-14. PubMed ID: 15944285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling.
    Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W
    BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.